Manuel J. Velez

Intellectual Property Counseling & Prosecution, Trademark Litigation, Intellectual Property

Visión general

Manuel Velez serves clients on patent infringement litigations and PTAB proceedings regarding pharmaceuticals, biotechnology, and medical devices. His experience runs the full gamut, from conducting pre-case assessments to managing litigations for innovator companies in high-stakes cases in federal courts. Manuel has been a member of trial teams that obtained favorable trial decisions and settlements for branded pharmaceutical clients in Hatch-Waxman and BPCIA litigations. He performs due diligence in connection with M&A transactions, including providing freedom-to-operate opinions.



  • Gilead in performing due diligence in connection with collaboration agreement with Lyndra Therapeutics to develop ultra-long-acting HIV therapeutics.
  • Gilead in performing due diligence in connection with collaboration agreement with Nurix Therapeutics to create new cancer medicines that break down disease-causing proteins.
  • IMS in performing due diligence in connection with six separate acquisitions. Work included analyzing the intellectual property portfolio and contracts relating to intellectual property assets.


  • Manuel was shortlisted as a US Rising Star in Intellectual Property by the LMG Life Sciences Awards.


  • Boston University School of Law, JD
    Merit-Based Tuition Scholarship; Article Editor of Public Interest Law Journal, Recipient of Faculty Academic Progress Award, Equal Justice America Fellowship
  • University of Florida, MS
    Florida Georgia Alliance Graduate Fellowship
  • University of Florida, PhD
    National Science Foundation Pre-Doctoral Fellowship
  • Cornell University, BA
    Dean's List


  • Nueva York


  • US District Court for the District of Puerto Rico


  • Spanish
  • French

Participación Profesional y Comunitaria

  • New York State Bar Association.